![Skin and intestinal GVHD responds to ruxolitinib. (a) A representative... | Download Scientific Diagram Skin and intestinal GVHD responds to ruxolitinib. (a) A representative... | Download Scientific Diagram](https://www.researchgate.net/profile/Walter-Velden/publication/280582098/figure/fig4/AS:667600057012229@1536179665526/Skin-and-intestinal-GVHD-responds-to-ruxolitinib-a-A-representative-patient-with_Q640.jpg)
Skin and intestinal GVHD responds to ruxolitinib. (a) A representative... | Download Scientific Diagram
![Transplantation's Greatest Challenges: Advances in Chronic Graft-versus-Host Disease - Biology of Blood and Marrow Transplantation Transplantation's Greatest Challenges: Advances in Chronic Graft-versus-Host Disease - Biology of Blood and Marrow Transplantation](https://www.astctjournal.org/cms/attachment/ded7e69a-54c1-4b96-989e-a84a99931fb4/gr1_lrg.jpg)
Transplantation's Greatest Challenges: Advances in Chronic Graft-versus-Host Disease - Biology of Blood and Marrow Transplantation
![Cutaneous Chronic Graft Versus Host Disease Following Allogeneic Haematopoietic Stem Cell Transplantation in Children: A Retrospective Study | HTML | Acta Dermato-Venereologica Cutaneous Chronic Graft Versus Host Disease Following Allogeneic Haematopoietic Stem Cell Transplantation in Children: A Retrospective Study | HTML | Acta Dermato-Venereologica](https://www.medicaljournals.se/acta/html-editor/html-img/5097/5097_9279.png)
Cutaneous Chronic Graft Versus Host Disease Following Allogeneic Haematopoietic Stem Cell Transplantation in Children: A Retrospective Study | HTML | Acta Dermato-Venereologica
![Measuring Therapeutic Response in Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group Report - Biology of Measuring Therapeutic Response in Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group Report - Biology of](https://www.astctjournal.org/cms/attachment/2004302352/2017876017/gr1.jpg)
Measuring Therapeutic Response in Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group Report - Biology of
![Cureus | Evidence-based, Skin-directed Treatments for Cutaneous Chronic Graft-versus-host Disease | Article Cureus | Evidence-based, Skin-directed Treatments for Cutaneous Chronic Graft-versus-host Disease | Article](https://assets.cureus.com/uploads/figure/file/78449/lightbox_fa0c6ca0c88311e998464519befe740a-Figure-1-arrows.png)
Cureus | Evidence-based, Skin-directed Treatments for Cutaneous Chronic Graft-versus-host Disease | Article
![Chronic Graft-Versus-Host Disease Mimicking Psoriasis in a Patient with Hemophagocytic Lymphohistiocytosis Chronic Graft-Versus-Host Disease Mimicking Psoriasis in a Patient with Hemophagocytic Lymphohistiocytosis](https://anndermatol.org/ArticleImage/0140AD/ad-28-90-g001-l.jpg)
Chronic Graft-Versus-Host Disease Mimicking Psoriasis in a Patient with Hemophagocytic Lymphohistiocytosis
![Graft‐versus‐host disease of the skin and adjacent mucous membranes - Ziemer - 2013 - JDDG: Journal der Deutschen Dermatologischen Gesellschaft - Wiley Online Library Graft‐versus‐host disease of the skin and adjacent mucous membranes - Ziemer - 2013 - JDDG: Journal der Deutschen Dermatologischen Gesellschaft - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/ffeee7bc-c4a3-43e5-8c89-87d0017e96f2/ddg12103-gra-0001.png)
Graft‐versus‐host disease of the skin and adjacent mucous membranes - Ziemer - 2013 - JDDG: Journal der Deutschen Dermatologischen Gesellschaft - Wiley Online Library
Oncoderm Labs - What is Graft Versus Host Disease? Graft-versus-host disease (GVHD) is an immune condition that occurs after transplant procedures when immune cells from the donor (known as the graft or
![Bortezomib for the treatment of chronic Graft Versus Host Disease in Intestinal Transplant recipient Bortezomib for the treatment of chronic Graft Versus Host Disease in Intestinal Transplant recipient](https://coms.events/cirta2019/data/img/u0296_s0300_p001_j47jvogq_GHVD_Skin_Before.png)
Bortezomib for the treatment of chronic Graft Versus Host Disease in Intestinal Transplant recipient
![Dermatologic Manifestations of Graft Versus Host Disease: Introduction, Clinical Overview, Pathophysiology Dermatologic Manifestations of Graft Versus Host Disease: Introduction, Clinical Overview, Pathophysiology](https://img.medscapestatic.com/pi/meds/ckb/62/6062tn.jpg)